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摘要
目的:研究老年性黄斑变性(AMD)等级、血清抗氧化维生
素水平(维生素 A、C 和 E)和吸烟的关系。
方法:对 84 例患者行黄斑彩色眼底成像,根据 AMD 损伤
率和损伤程度将其分为五组(等级 I ~ V)。 应用高效液相
色谱法(HPLC)测量血清抗氧化维生素水平。 根据吸烟状
况分不吸烟者、已戒烟者和吸烟者三组,并统计吸烟者每
年的吸烟总量。
结果:对照组中,维生素 A、E、C 水平分别为0.874依0.326mg/ L,
10.739依4.874mg/ L 和 1. 737依0. 447mg/ L,AMD 组中分别
为 0. 880 依 0. 305mg/ L,9. 487 依 6. 060mg/ L 和 1. 870 依
2郾 191mg/ L,无显著差异(P>0. 05)。 AMD 不同等级分组
间维生素 A(P=0. 881)和 E(P=0. 293)水平差异无统计
学意义,维生素 C 水平(P=0. 044)随 AMD 程度的加深而
增加。 根据吸烟状况,AMD 组与对照组之间无显著差异。
根据每年的吸烟总量,两组之间有显著差异(P= 0. 02)。
AMD 越严重,年吸烟总量越高(P=0. 007)。
结论:研究结果显示 AMD 与维生素 A、E 血清水平无关,
但和维生素 C 的血清水平相关,并与吸烟量有关。
关键词:吸烟;抗氧化维生素;老年性黄斑变性
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Abstract
誗AIM: To evaluate associations between the grades of
age related macular degeneration ( AMD) and serum
levels of antioxidant vitamins (vitamin A, C and E) and
smoking.
誗METHODS: Fifty-three AMD patients and 31 individuals
having ages matching with the patient group were
enrolled the study. Colored fundus photographs of the
macula were used to place participants (n = 84) into one
of the five groups (Grade I- V) based on the frequency
and severity of the lesions associated with AMD. Serum
antioxidant vitamin levels were measured using High
Performance Liquid Chromatography ( HPLC). Smoking
status was classified as non - smoker, ex - smoker and
current smoker. Total number of packs smoked per year,
was defined.
誗RESULTS: The distribution of vitamin A, E, and C levels
were 0. 874 依 0. 326mg/ L, 10. 739 依 4. 874mg/ L, 1. 737 依
0郾 447mg/ L in control group and 0.880依0.305mg/ L, 9.487依
6.060mg/ L, 1. 870依2. 191mg/ L in AMD group, respectively.
The difference between AMD and control group was not
statistically significant for vitamin A, E and C levels (P>
0郾 05). There were no significant differences between
subgroups of AMD for vitamin A (P=0.881) and vitamin E
(P=0.293) but there was a contradicting rise of vitamin C
levels (P = 0. 044) with increasing levels of the disease.
There were no significant differences between AMD and
control group regarding smoking status, but there was a
significant difference for total number of packs smoked
per year (P=0.02). An increase of number of total packs
smoked per year was determined along with the rising
grade of AMD (P=0.007).
誗CONCLUSION: We found no relation between AMD and
serum levels of vitamin A and E but vitamin C levels was
increase with AMD grades unexpectedly. We found dose-
response relationship between smoking and AMD.
誗KEYWORDS:smoking; antioxidant vitamin; age related
macular degeneration
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A
ge related macular degeneration (AMD) affect Bruch蒺s
membrane, choriocapillaris and retinal pigment
epithelium. It is of progressive, degenerative and bilateral
character
[1,2]. The prevalence of AMD is 1. 7% in the
population
[3]. AMD is the leading cause of blind registration
in the western world, and its prevalence is likely to rise as a
consequence of increasing longevity
[1,2].
The exact etiology of AMD is not known. During recent years,
oxidative stress has been implicated in many disease
processes, especially for age - related disorders and the
pathogenesis of the AMD. One prominent hypothesis of aging
proposes that oxidative damage to cells, initiated by free
radicals, is an important cause of the aging process. The
retina is particularly susceptible to oxidative stress because of
its high consumption of oxygen, high proportion of
polyunsaturated fatty acids, and exposure to visible light.
Among the risk factors, genetic defect for antioxidant enzymes
( peroxidase, superoxide dismutase ), decreased dietary
consumption of antioxidant vitamins, and environmental
factors (smoking) have been implicated. The extent of the
tissue damage is the result of the balance between the
generated free radicals and the antioxidant protective defense
system
[4-10].
In this study we investigated the relations between smoking
status, blood antioxidant vitamin levels, and grade of AMD.
SUBJECTS AND METHODS
In the present cross-sectional study, 53 patients who were
aged 50 or more and had been followed up in the retinal unit
due to AMD of various grades between February 2006 and
June 2006, were enrolled alongside 31 individuals having ages
matching with the patient group who had come to our
polyclinic. Patients who had pathologies such as degenerative
myopia, traumatic choroidal rupture, ocular histoplasmosis
which could lead to CVNM and ones who were using vitamin
preparations, were not included in the study.
Smoking status at the time of the examination was determined
as follows: nonsmoker, if one had smoked less than 100
cigarettes in his/ her lifetime; ex-smoker, if one had smoked
more than 100 number of cigarettes in his/ her lifetime but had
stopped smoking before the examination; current smoker if
one had not stopped smoking. Amount of total pack/ years
smoked was defined as the number of cigarettes smoked per
day divided by 20, multiplied by the number of years
smoked.
BMIs of the enrolled individuals in patient and control groups,
were measured by determining their weight and height.
Ophtalmologic Examination and Determination of
Grades摇 Complete ophtalmologic examination was performed
on both patient and control groups. After determining the best
corrected visual acuity of individuals, 1% tropicamide was
applied to dilate the eyes of people in patient and control
groups. Indirect ophtalmoscopic examination was carried out
by a Volk lense of 90D, and fundus was photographed.
During grading of the patients, AREDS grading system was
employed
[6,7]. In patients who had different AMD grade for
each eye, the results of the eye with a higher grade was
included in the study.
Biochemical Measurements摇 Values for parameters such as
vitamin A, vitamin E, vitamin C, hemoglobin, fasting blood
sugar, cholesterol, triglyceride, HDL, LDL, VLDL, were
investigated for patient and control groups.
Blood samples of patient and control groups were obtained
after at least 8 hours of a fasting period, and then stored in a
refrigerator at -20益. After obtaining blood samples of all the
individuals in patient and control groups, biochemical analysis
was performed on the same day.
Measurement of Total Cholesterol, Triglyceride, High
Density Lipoprotein, Low Density Lipoprotein and Very
Low Density Lipoprotein in Serum摇 Measurements were
carried out by calorimetric method in a Dax 48 Tecnicon
autoanalyzer and kits belonging to Biocon company were used.
Normal range of values were as follows: total cholesterol 100-
200mg/ dL, triglyceride 30 - 150mg/ dL, HDL > 65mg/ dL,
LDL<130mg/ dL.
Measurement of Serum Vitamin A and E Values摇 Reverse-
phase HPLC and UV detection methods were employed for
biochemical assays. Chromatographic system was comprised of
Thermo Finnigan Spectra Model high performance liquid
chromatography ( HPLC) device, P1000 pump, AS3000
autosampler, Spectra UV1000 UV detector, SCM1000
degasser unit and SN4000 system control unit. Moreover, a
column calibrated to 30毅 was employed. For mobile phase,
isocratic elution was performed at 295 and 325nm with Recipe
Vitamin A-E HPLC Detection Kit at 1. 5mL/ min flow rate.
During measurements, 琢-tocoferol for vitamin E and all-trans-
retinol for vitamin A, were used as a standard.
While the Level 1 values of the control used forvitamin A
ranged between 0.78 and 1.08, the mean value was 0.90mg/ L.
Level 2 values of the control varied between 1. 18 and
1郾 76mg/ L, and the mean value was 1. 47mg/ L. Level 1
values of the control employed for vitamin E ranged between
12. 2 and 18.2, and the mean value was 15.2. Level 2 values
of the control varied between 20. 0 and 30. 0, and the mean
value was 25. 0.
Measurement of Serum Vitamin C Value摇 Reverse-phase
HPLC and ultraviolet (UV) detection methods were employed
for measuring serum Vitamin C levels. The device mentioned
above was used for the measurements along with using
125mm 伊 4mm and 5滋m Bischoff Prontosil AQ columns.
Isocratic elution was used with methanol at 0. 75mL/ min flow
rate as mobile phase. Level 1 values for the control used for
vitamin C, varied between 2. 6 and 5. 4mg/ L, but the mean
value was 4. 0mg/ L. The values of control for Level 2 ranged
between 13.9-23. 1, and the mean value was 18.5mg/ L.
Statistical Analysis摇 The comparisons between patient and
control groups and AMD grades were carried out according to
the distribution characteristics by employing parametric and
nonparametric tests. Results were presented as mean依standard
deviation values. Correlations between vitamin values and
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AMD grades; were evaluated by using Pearson or Spearman
correlation coefficient, if applicable. Values found to be
significant with vitamin values in univariate analysis, were
corrected by employing general linear model. The distribution
among the corrected values was compared by again applying
One - way ANOVA test. P < 0. 05 was recognized as
statistically significant. SPSS/ PC 10. 0 (SPSS Inc. Chicago,
IL) was used for statistical evaluations.
RESULTS
Control group was consisted of 31 individuals; while 26 had
complete vision, 4 had 0. 8, and 1 had 0. 7 vision. Senile
cataract was the reason behindthe lesser degree of vision in
those 5 individuals. A description of study participants is
given in Table 1. The difference between AMD and control
group was not statistically significant regarding these features.
Smoking status in control and AMD groups, is given in Table 2.
While there was no significant difference between the 2 groups
in terms of smoking status (P=0. 09), there was a significant
difference between them regarding the amount of cigarettes
smoked (P=0. 02).
In all cases, correlations betweenvitamin A, E, and C levels,
and demographic and biochemical values, were investigated.
While no correlation was found between serum vitamin A level
and the investigated values, a statistically significant
correlation was detected between serum vitamin E level, and
Hg (r=0.25), and serum Cho. level (r=0. 22, P=0. 04),
whereas serum vitamin C level showed statistically significant
correlation with age (r=0. 26, P=0. 01). Corrected results
of the vitamins were employed in the assesments.
Mean values of vitamin A, E, Cmeasured in patient and
control groups, are shown in Table 3. No statistically
significant difference was found between patient and control
groups regarding vitamin A (P = 0. 932), vitamin E (P =
0郾 330), and vitamin C (P=0. 797) values. AMD group was
consisted of 53 people. While 12 had complete vision, 2 had
0. 9 vision, 9 had 0.8 vision, 10 had 0.7, 4 had 0. 6, 1 had
0. 4, 2 had 0. 3, 1 had 0. 2, 1 had 0.16, 2 had 0. 05, and 9
had <0. 05 vision.
Demographic characteristics, biochemical values, and
accompanying risk factors forAMD patients regarding the
grades, are shown in Table 4.
No statistically significant difference was found between the
grades regarding all the parameters except age, whereas the
age difference between grade 2 and 3, and grade 2 and 4,
were statistically significant ( P = 0. 002). Smoking status
distribution among AMD group according to the grades, is
shown in Table 5.
While there was no significant difference between AMD grades
in terms of smoking status ( 资
2 = 0. 441), the difference
between grades regarding amount of smoked cigarettes, was
determined to be significant (P=0.007). There were significant
differences between grade 3 and 4, grade 3 and 5, grade 2
and 4, and grade 2 and 5. Serum vitamin A, E, C levels of
AMD group in terms of grades, are shown in Table 6.
Table 1 Baseline characteristics of participants in the control
and AMD group
Variable
Control group
(n=31)
AMD group
(n=53)
1P
Age (a) 69. 77依8. 01 72. 36依9. 63 0. 21
Sex
摇 Male 11 (35. 5%) 24 (45. 3%)
摇 Female 20 (64. %5) 29 (54. 7%)
20. 49
BMI (kg/ m
2) 29. 26依4. 25 27. 49依5. 11 0. 11
Hg (g/ dL) 13. 07依1. 50 13. 24依1. 47 0. 60
FBS (mg/ dL) 109. 64依29. 50 110. 62依27. 39 0. 87
Chol (mg/ dL) 197. 97依39. 59 210. 21依38. 16 0. 16
TG (mg/ dL) 124. 19依42. 95 129. 40依70. 05 0. 70
HDL (mg/ dL) 57. 64依14. 98 60. 26依13. 74 0. 41
LDL (mg/ dL) 115. 03依37. 38 123. 44依31. 98 0. 27
VLDL(mg/ dL) 25. 04依8. 56 25. 98依11. 80 0. 70
HT
摇 Present 23( 74. 2%) 37 (69. 8%)
摇 Absent 8 (25. 8%) 16(30. 2%)
0. 80
DM
摇 Present 11 (35. 5%) 14 (26. 4%)
摇 Absent 20 (64. 5%) 39 (73. 6%)
0. 46
BMI: Body mass index, Hg: Hemoglobin, FBS: Fasting blood
sugar, Chol: Cholesterol, TG: Triglyceride, HDL: High density
lipoprotein, LDL: Low density lipoprotein, VLDL: Very low density
lipoprotein, HT: Hypertension, DM: Diabetes Mellitus;
1 t-test,
2 Chi-square test.
Table 2摇 Cigarette smoking status in control and AMD groups
Smokingstatus
Control group
n=31 (%)
AMD group
n=53 (%)
2P
Non-smoker 15 (48. 4%) 26 (49. 1%)
Ex-smoker 14 (45. 2%) 24 (45. 3%) 0. 99
Currentsmoker 2 (6. 5%) 3 (5. 7%)
Pack/ a 7. 20 16. 78
10. 02
1 t-test,
2 Chi-square test.
Table 3摇 Plasma vitamin A, E, C levels of control and AMD
groups
Variable
Control group
(n=31)
AMD group
(n=53)
1P
Vitamin A (mg/ L) 0. 874依0. 326 0. 880依0. 305 0. 932
Vitamin E (mg/ L) 9. 70依1. 27 10. 09依1. 23 0. 17
Vitamin C (mg/ L) 1. 73依0. 44 1. 50依0. 55 0. 16
1 t-test.
While there was no significant difference between AMD
grades, and vitamin A (P=0. 881) and E (P=0. 28); the
difference of vitamin C level (P = 0. 881) was statistically
significant betwen grade 1 and 4, grade 2 and 3, and grade 2
and 4.
DISCUSSION
Previous studies have shown that age is a risk factor in
development of AMD
[11,12]. For example, Hirvela et al
[11]
conducted an epidemiologic study on 560 people and after
investigating several risk factors such as age, hypertension,
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Variable Grade 2 n=16 Grade 3 n=15 Grade 4 n=7 Grade 5 n=15 P
Age 65. 68依9. 97 74. 47依9. 20 80. 00依5. 54 73. 80依7. 27 0. 002
Sex
摇 M 6 (37. 5%) 7 (46. 7%) 4 (57. 1%) 7 (46. 7%)
摇 F 10 8 3 8
0. 809
BMI 28. 40依5. 88 27. 17依4. 42 24. 21依2. 67 28. 39依5. 50 0. 139
Hg 13. 48依1. 64 13. 06依1. 42 12. 37依1. 82 13. 58依1. 05 0. 39
FBS 104. 25依27. 52 116. 20依30. 82 92. 43依8. 04 120. 33依25. 52 0. 18
Chol 223. 81依41. 07 205. 80依45. 61 196. 29依26. 75 206. 60依29. 53 0. 27
TG 135. 50依68. 50 147. 93依98. 03 92. 57依24. 58 121. 53依46. 63 0. 35
HDL 59. 75依17. 36 59. 46依12. 20 60. 14依12. 55 61. 66依12. 58 0. 93
LDL 133. 56依35. 84 122. 00依32. 53 114. 71依28. 70 118. 15依28. 70 0. 49
VLDL 31. 06依14. 07 25. 13依11. 78 19. 29依5. 56 24. 53依9. 89 0. 14
HT present 11 (68. 8%) 12 (80. 0%) 3 (42. 9%) 11 (73. 3%) 0. 472
DM present 3(18. 8%) 6 (40. 0%) - 5 (33. 3%) 0. 265
摇 摇 Table 5摇 Smoking status in all categories of AMD groups
Smokingstatus Category 2 n=16(%) Category 3 n=15(%) Category 4 n=7(%) Category5 n=15(%)
1P
Non-smoker 9(56. 3 %) 10(66. 7%) 2(28. 6%) 5(33. 3%)
Ex-smoker 5(31. 3%) 5(33. 3%) 5(71. 4%) 9(60. 0%)
20. 441
Currentsmoker 2(12. 5%) 0(0%) 0(0%) 1(6. 7%)
Pack/ a 12. 28 9. 58 25. 59 24. 67
30. 007
摇 摇
1Kruskal Wallis test,
2Chi-square,
3Statistically significant.
Table 6摇 Plasma vitamin A, E, C levels of all AMD groups
Variable Category 1 n=31 Category 2 n=16 Category 3 n=15 Category 4 n=7 Category 5 n=15
1P
Vit. A (mg/ L) 0. 874依0. 326 0. 815依0. 213 0. 924依0. 505 0. 934依0. 129 0. 879依0. 160 0. 881
Vit. E (mg/ L) 9. 81依2. 06 10. 23依1. 91 10. 06依1. 79 10. 39依1. 41 9. 60依1. 64 0. 28
Vit. C (mg/ L) 1. 73依0. 44 1. 51依0. 55 1. 99依0. 51 2. 31依0. 31 1. 96依0. 40
20. 002
Vit. : Vitamin;
1One-way ANOVA,
2Statistically significant.
diabetes, smoking, myopia, they found only age to have an
influence over AMD development. Another BDES study
performed by Klein et al
[12] which had the title of “Five-year
incidence of age-related macular degeneration冶, underscored
the importance of age both in early and late stage AMD.
In the present study, we determined age as an effective risk
factor for grade of AMD disease. While mean age ofAMD
patients and control group, did not show any statistically
significant difference, the difference between grades in the
patient group was found to be statistically significant (P =
0郾 002). The age differences between grade 2 (mean 65. 68)
and grade 3 (mean 74.47), and between grade 2 and grade 4
(mean 80. 00) were statistically significant.
Many epidemiologic studies showed smoking as an important
risk factor for AMD
[13-24]. Several studies yielded results
which indicated the influence of smoking was dependent on
dose
[16]. Beaver Dam Eye Study showed that smoking elevates
exudative AMD. Exudative AMD was found to have a 2. 5
times higher incidence among current smokers compared to
those of ex-smokers or nonsmokers (relative risk 2. 5; 95%
CI 1. 01 - 6. 20). Among males, exudative AMD risk in
current smokers was found to be 3. 29 times more than ex-
smokers or nonsmokers (relative risk 3. 29, 95% CI:1. 03-
10. 50). POLA study showed late stage AMD risk as 3. 6
times higher among current smokers compared to those of
nonsmokers.
[14] Rotterdam Eye Study performed in Holland
found the neovascular AMD risk among current smokers who
were below 85 age, as 6. 6 times higher than that of
nonsmokers. Moreover, neovascular AMD risk has been found
to be 3.2 times higher among ex-smokers compared to that of
nonsmokers. The evaluation of the amount of cigarettes
smoked, showed a significant elevation in AMD development
risk for people who smoke 10 packs or more per year (relative
risk 6. 5; 95%CI: 2.9-14. 8)
[16]. Furthermore, smoking is
thought to have an influence over disease development due to
its effects such as decreasing serum antioxidant level,
reducing choroidal blood flow or increasing atherosclerosis
[16].
A study conducted by AREDS in 2005, found correlation
between smoking, and neovascular AMD (OR:1. 55, 95%
CI:1.15-2. 09) and central geographic atrophy (OR:1. 82,
95%CI:1. 25 -2. 65) depending on the dose ( >10 pack/
year)
[17].
In the present study, no difference was found between control
and patient groups regarding number of current smokers.
While 45. 3% of AMD group was ex -smoker, 5. 7% was
current smoker. The 45.2% of control group was ex-smoker,
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2 = 0. 99). However,
regarding the evaluation of the amount of smoked cigarettes in
terms of pack/ year, there was a significant difference between
the patient and control groups. While the mean amount of
smoked cigarettes was 16. 78/ pack/ year in AMD group, it
was 7. 20 pack/ year in control group ( P = 0. 02). An
assessment carried out between grades of AMD group in
smokers, ex -smokers, and nonsmokers; but no significant
difference was found between them (P = 0. 99), however,
there was a significant difference in terms of the amount of
cigarette smokers in pack/ year (P= 0. 007). While the rate
was 12. 28 pack/ year in stage 2, it was 9. 58 pack/ year in
grade 3. Grade 4 had a rate of 25. 59 pack/ year and grade 5
had a rate of 24. 67 pack/ year. The amount of cigarettes
smoked in late stage AMD (grade 4 and 5), was significantly
higher than that of early stage AMD (grade 2 and 3) (P =
0郾 007). This result suggested that the influence of smoking
was dependent on the dose and had a correlation with the
severity of the disease.
Studies performed to show the association between AMD and
antioxidant vitamins
[25-31], yielded different results. While
some showed no association
[32,33], some showed antioxidant
vitamins as protective against wet type AMD
[4,34,35].
EDCC study found a link between vitamin A and AMD
[34].
EDCC carried out the investigation on that manner between
1986-1990. 421 neovascular AMD patient (mean age 71)
and 615 (mean age 68) control group were enrolled in the
study. Serum carotenoid, vitamin C, vitamin E, and
selenium values of patient and control groups were compared.
Serum vitamin A, E, C values were measured as 滋mol/ L and
classified as low, medium, and high. Neovascular AMD risk
in the group which had an medium and high serum carotenoid
levels (Vitamin A), was found to be significantly lower than
the group that had a lower serum carotenoid level. While
medium carotenoid level reduced the neovascular AMD risk to
50%, high carotenoid level decreased this risk to 30%.
However, no significant difference could have been found in
comparisons made between values of serum vitamin C, vitamin
E, and selenium
[34].
The Blues Mountains Eye Study ( BMES) conducted by
Smithet al
[33] did not find any association between antioxidant
level and AMD, as well. The evaluation of the results showed
no significant difference between antioxidant or supplemental
vitamins taken by diet and early or late stage AMD
[33].
In the present study, similar to the other studies (POLA,
BLSA, BDES, BMES) in the literature except EDCC, no
link was found between vitamin A and AMD. While the
vitamin A value of control group was 0. 874依0. 326mg/ L, it
was 0. 880依0. 305mg/ L ifor AMD group. The comparison of
AMD and control groups revealed no statistically significant
difference in terms of vitamin A values (P=0. 932).
The distribution of vitamin A among grade 2 - 5, were as
follows: 0. 815依0. 213mg/ L, 0. 924依0. 505mg/ L, 0. 934依
0郾 129mg/ L, 0.879依0.160mg/ L respectively; and there was
no significant difference between them (P=0. 881).
Two studies found an association between vitamin E and
AMD: POLA and BLSA
[4,19].
The first study which found a link between vitamin E and
AMD, was the POLA study conducted by Delcourt et al
[4] in
France. They detected a weak negative relationship between
vitamin E (serum 琢-tocoferol) level and late stage AMD (P=
0. 07). However, after making an adjustment according to the
serum lipid level, a significant negtive link has been found
between serum 琢-tocoferol level and late stage AMD (P =
0郾 003). Late stage AMD risk in the group with high vitamin
E level, was found to be 82% lower than that observed in the
group with low vitamin E level. Moreover, a significant
correlation has been found between vitamin E level adjusted
according to the lipid level and early findings of AMD (P =
0郾 03 ). However, no significant correlation has been
determined betwen serum vitamin A and vitamin C levels, and
AMD findings
[4].
The second study showing the protective nature of vitamin E
over AMD, was performed by Westet al
[36] between 1988 -
1990 on 976 patients selected among a BLSA population.
According to their fundus photographs, patients were grouped
in two as mentioned above: early stage AMD and late stage
AMD. In the end of the study, 琢-tocoferol was found to have
a statistically significant protective property against early stage
AMD; while it was protective against the late stage too, this
was not statistically significant. Moreover, the assessment of
琢-tocoferol (vitamin E), ascorbic acid (vitamin C), and
茁-carotene, all of which have been mentioned as antioxidant
index, were found to be protective against early stage AMD.
However, supplemental vitamin use was not determined to be
a significant protective factor against AMD (OR=0. 9, 95%
CI: 0.6-1.3)
[36].
Studies other than POLA and BLSA, showed no association
between vitamin E and AMD
[32-34,37-39].
One of the studies which shows no association between vitamin
E and AMD, is the case - control study performed by
Perlmanet al
[37] which categorized AMD as early and late
stage. In the present study, we divided AMD into 4 grades
and therefore, had the chance to evaluate in a more detailed
manner. Their study found mean serum vitamin E level to be
lower in the group with wet type AMD (P=0. 03). However,
when an adjustment was made for vitamin E based on the
serum cholesterol levels, the difference was determined to be
insignificant.
In the present study, we detected no link between serum
vitamin E levels and AMD. While vitamin E was 10. 739 依
4郾 874mg/ L in the control group, it was 9. 487依6. 060mg/ L
in the AMD group. The difference of vitamin E values
between patient and control groups was not statistically
significant (P=0.330).
The correlation of serum vitamin E level with the cholesterol
level was found to be significant ( r = 0. 22, P = 0. 04).
Vitamin E level adjusted according to the cholesterol value,
was found to be 9. 70依1. 27mg/ L and 10. 09依1. 23mg/ L in
control and AMD groups, respectively. The difference
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significant again (P=0.330).
The distributions of vitamin E between grades 2 -5 were as
follows: 7. 414依6. 965mg/ L; 9. 951依6. 387mg/ L; 12. 240依
5. 500mg/ L; 9. 949 依 5. 653mg/ L; and the differences
between them were not statistically significant (P = 0. 293).
The differences between vitamin E values adjusted according
to the cholesterol values in AMD grades, were again
statistically insignificant (P=0.28).
Regarding the studies carried out to show the association
between AMD and vitamin C, it can be observed that no
significant correlation could have been found
[4,33,34,36,38]. In
the present study, we did not detect any significant correlation
between AMD and vitamin C, as well. Vitamin C levels
between control and AMD groups were 1. 737依0. 447mg/ L;
1.870依2. 191mg/ L, respectively; and the difference between
them was not statistically significant (P = 0. 797). In our
study, the correlation between serum vitamin C level and age,
was found to be significant. Vitamin C level adjusted
according to the age was 1. 73 依0. 44mg/ L in control group
and 1. 50依0.55mg/ L in AMD group. The difference between
AMD and control group was not significant again (P=0. 16).
In the present study, contrary to the general expectation which
predicts vitamin C level to drop as the grade of the disease
advances, it was found to be higher in advanced grades (P=
0. 002).
Although there are many studies which did not show any link
between antioxidant vitamins and AMD, because it had
decreased the loss of vision and progression of the disease in a
placebo-controlled, double-blind clinical study of AREDS
conducted between 1992-1998, AREDS recommends high-
dose antioxidant vitamin (50mg vitamin C, 400IU vitamin E,
15mg 茁-carotene) and 80mg Zn
[30,40]. Since it is not possible
to determine the antioxidant agents in retina in vivo, we can
measure their serum levels. However, by those instantaneous
measurements, we can not know if the patient has adequate
antioxidant throughout one蒺s life. Particularly in elderly
individuals in whom any deficiency is not observed,
prescribing excessive vitamin and minerals seems risky to us
since the side effects and indications have not been clearly
outlined yet.
In light of those results, we believe that the role which
deficiency of antioxidant vitamins play over etiology and
grading of AMD, is not of primary character. However, the
fact that our study was more cross-sectional than prospective,
and that antioxidant vitamin values measured once might not
show a direct correlation with the AMD findings occurring as a
result of a changes throughout a lifetime, were the limitations
of our study. The present study rather provides us information
on vitamin values observed in AMD group alongside suggesting
higher incidence of advanced grades in smoking individuals.
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